Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

The 'painful' side effect reported to develop in small number of cases a month after Covid booster jab

A new case study documents cases of a painful skin condition that emerges one month after people received the booster dose of the Pfizer vaccine

Irish Mirror

Some People Reckon They Have Post-Vax Perky Nipples, Which Is Deff More Fun Than A Sore Arm

An influencer described having "high beam" nipples.

Pedestrian.tv

Boosters increase protection against death from Omicron in over-50s to 95% – UKHSA; UK records 338 deaths – as it happened

Protection against death increases to around 95% two weeks after receiving a booster dose, UK health agency says; UK reports another 96,871 Covid cases

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Young kids get 1st shots on Monday

The Ministry of Public Health will give the first round of Pfizer's Covid-19 vaccine to children aged five to 11 on Monday.

Bangkok Post

Youngsters to get 1st shots on Monday

The Ministry of Public Health is ready to provide the first round of Pfizer's Covid-19 vaccine to children aged five to 11 on Monday at the Queen Sirikit National Institute of Child Health.

Bangkok Post

COVID-19 oral antivirals have been embraced in the US and could be a pandemic game changer

It sounds too good to be true: a course of antivirals you can take at home to alleviate your symptoms if you're at risk of dying or being hospitalised with COVID-19. But the drugs are landing in Australia in the coming weeks.

ABC News

Omicron-hit may escape reinfection with Delta variant

ICMR conducted a study on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Covid briefing: Six things as isolation rules change in Wales and Sue Gray report could be published today

It is being reported that the Downing Street investigation was given photographs of parties showing the Boris Johnson next to wine bottles

Wales Online

UK reports 346 daily deaths; Denmark aims to end all restrictions – as it happened

UK also records over 102,000 daily cases; Danish plan would mean most far-reaching easing among Nordic countries

The Guardian - AU

Morning Digest | Gen. Rawat, Kalyan Singh awarded Padma Vibhushan; Pfizer starts Omicron-specific COVID-19 vaccine trial; and more

A select list of stories to read before you start your day

The Hindu

COVID updates: Get up to speed on all the coronavirus news from across Australia — as it happened

Keep up to date with all the COVID-19 news from across Australia.

ABC News

Pfizer starts Omicron-specific COVID-19 vaccine trial

The trial will involve 1,420 people aged 18-55.

The Hindu

Anthony Fauci says Omicron-specific COVID-19 vaccine may be prudent but not needed, as clinical trials announced

A COVID-19 vaccine specifically targeting the Omicron variant would be "prudent", even if it ultimately may not be needed, the top US infectious disease official says, as Pfizer announces trials for such a vaccine.

ABC News

Pfizer begins trials of 'tweaked' Covid jab amid fears of waning protection against Omircron

"Emerging data indicate vaccine-induced protection against infection and mild to moderate disease wanes more rapidly than was observed with prior strains"

Irish Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Pfizer and BioNTech launch clinical trial for Omicron-specific vaccine

Pfizer Inc and BioNTech have announced the start a clinical trial to test a new version of their vaccine specifically designed to target the Omicron variant of Covid-19 Omicron variant.

Tribune News Service

Pfizer, BioNTech begin study of omicron-specific COVID vaccine

Pfizer Inc. said it is starting a study of a COVID-19 vaccine that targets the omicron variant, exploring its use in previously vaccinated younger and middle-aged adults as well as those who haven’t received another coronavirus shot.

Benzinga

Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have

Asharq Al-Awsat

Pfizer and BioNTech Launch Trial of Omicron-Targeted COVID Vaccine

Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. The companies plan to test the immune…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

The Independent UK

Pfizer opens study of COVID shots updated to match omicron

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant

Axios

Pfizer begins clinical trial for Omicron-specific COVID vaccine

Omicron's rise has forced vaccine makers to reassess the effectiveness of their vaccines.

The Guardian - UK

Pfizer launches Omicron vaccine trial; UK reports highest daily deaths since February – as it happened

Company hopes vaccine will be ready for approval by March; UK reports 439 deaths and more than nearly 95,000 cases

Benzinga

Check Out What Whales Are Doing With PFE

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:

The Conversation

How mRNA and DNA vaccines could soon treat cancers, HIV, autoimmune disorders and genetic diseases

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines.…

1 … 67 68 69 70

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

2,470 stories

UKHSA

2,188 stories

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.